0000950170-23-041528.txt : 20230810 0000950170-23-041528.hdr.sgml : 20230810 20230810185605 ACCESSION NUMBER: 0000950170-23-041528 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230810 FILED AS OF DATE: 20230810 DATE AS OF CHANGE: 20230810 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Cannon Gillian CENTRAL INDEX KEY: 0001833910 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36687 FILM NUMBER: 231161076 MAIL ADDRESS: STREET 1: C/O CORCEPT THERAPEUTICS INCORPORATED STREET 2: 149 COMMONWEALTH DRIVE CITY: MENLO PARK STATE: CA ZIP: 94025 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Xenon Pharmaceuticals Inc. CENTRAL INDEX KEY: 0001582313 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 980661854 STATE OF INCORPORATION: A1 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 200 - 3650 GILMORE WAY CITY: BURNABY STATE: A1 ZIP: V5G 48W BUSINESS PHONE: (604) 484-3300 MAIL ADDRESS: STREET 1: 200 - 3650 GILMORE WAY CITY: BURNABY STATE: A1 ZIP: V5G 48W 4 1 ownership.xml 4 X0508 4 2023-08-10 0001582313 Xenon Pharmaceuticals Inc. XENE 0001833910 Cannon Gillian 200 - 3650 GILMORE WAY BURNABY Z4 V5G 4W8 CANADA (FEDERAL LEVEL) true false false false false Stock Option (Right to Buy) 38.39 2023-08-10 4 A false 28000 0 A 2033-08-09 Common Shares 28000 28000 D One-third of the total shares subject to the Option shall vest on the first anniversary of August 8, 2023 (the "Start Date"), one-third on the second anniversary of the Start Date and the balance on the third anniversary of the Start Date. /s/ Cassandra Robinson, Attorney-in-fact 2023-08-10